Heather Banuelos
Washington, D.C.
+1 202 626 2923
Heather Banuelos
Washington, D.C.
+1 202 626 2923
News
-
In the News |February 3, 2026Heather Bañuelos discusses the FDA increasingly citing promotional claims based on time-to-event endpoint data from single-arm trials
-
In the News |September 10, 2025Heather Banuelos comments on the FDA issuing about 100 letters directing sponsors to cease violative promotions under a new “crackdown” on deceptive drug advertising that targeted DTC risk-benefit balance problems
-
In the News |June 17, 2025Heather Bañuelos discusses the U.S. Food and Drug Administration’s launching a burst of enforcement activity targeting prescription drug promotion
-
In the News |November 20, 2023Heather Banuelos discusses the FDA’s final rule on the presentation of the "major statement" about a prescription drug's side effects and contraindications in direct-to-consumer television and radio ads
Insights
-
Article |June 3, 2026FDA Issues New Draft Guidance Addressing Communications with Payors
-
Article |January 21, 20262025 Year in Review: FDA Drug and Device Advertising and Promotion Enforcement
-
Article |December 9, 2025United States: Pharmaceutical Advertising
-
Article |October 6, 2025Drug Ad Crackdown Demonstrates Admin's Aggressive Stance
Events
Offices
On the Ground Where Our Clients Need Us
King & Spalding's global footprint includes 26 offices in the key business and financial centers around the world.